Austedo (Deutetrabenazine) by Teva: Understanding This Prescription Medication

Austedo, known generically as deutetrabenazine, is a prescription medication developed and manufactured by Teva Pharmaceutical Industries.


Austedo (Deutetrabenazine) by Teva: Understanding This Prescription Medication

Austedo, known generically as deutetrabenazine, is a prescription medication developed and manufactured by Teva Pharmaceutical Industries. It is specifically approved for the management of involuntary movements associated with certain neurological conditions. For individuals seeking information about Austedo Teva, understanding its purpose, how it functions, and key considerations is important.

What is Austedo (Deutetrabenazine)?

Austedo is a brand-name prescription drug that contains the active ingredient deutetrabenazine. It belongs to a class of medications known as vesicular monoamine transporter 2 (VMAT2) inhibitors. Teva Pharmaceutical Industries, a global leader in generic and specialty medicines, is the manufacturer responsible for bringing Austedo to patients.

As a VMAT2 inhibitor, Austedo works to modulate the levels of certain neurotransmitters in the brain, particularly dopamine, which are involved in controlling movement. This mechanism helps to reduce the severity of abnormal involuntary movements seen in its approved indications.

Approved Uses of Austedo

Austedo is approved by regulatory bodies, such as the U.S. Food and Drug Administration (FDA), for the treatment of two distinct neurological movement disorders:

Tardive Dyskinesia (TD)

Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive body movements. These movements most commonly affect the face, lips, tongue, and jaw, leading to grimacing, tongue protrusion, lip smacking, or rapid eye blinking. It can also affect the limbs and trunk, causing jerking or twisting motions. Austedo is prescribed to help reduce these involuntary movements in adults with TD.

Chorea Associated with Huntington's Disease (HD)

Huntington's disease is a progressive neurodegenerative disorder that causes uncontrolled movements, cognitive decline, and psychiatric problems. Chorea, a prominent symptom of HD, refers to irregular, unpredictable, involuntary movements that flow from one body part to another. Austedo is indicated to help lessen the severity of chorea in adults with Huntington's disease.

How Does Austedo Work?

The mechanism of action for Austedo involves its ability to reversibly inhibit VMAT2. VMAT2 is a protein responsible for packaging neurotransmitters like dopamine, serotonin, and norepinephrine into vesicles for storage and subsequent release in the brain.

By inhibiting VMAT2, Austedo reduces the amount of dopamine released in certain areas of the brain that are overactive in conditions like tardive dyskinesia and Huntington's disease chorea. This reduction in dopamine signaling helps to normalize neural activity and decrease the involuntary movements experienced by patients.

Important Considerations and Safety Information

While Austedo can be an effective treatment for its approved uses, it is a powerful medication that requires careful consideration and professional guidance. This information is for general understanding and is not a substitute for medical advice from a qualified healthcare provider.

Dosage and Administration

Austedo is an oral medication, typically taken by mouth. The exact dosage and administration schedule are determined by a healthcare professional based on the individual patient's condition, response to treatment, and tolerability. It is crucial to follow the prescribed dosage strictly and not to adjust it without consulting a doctor.

Potential Side Effects

Like all medications, Austedo can cause side effects. Common side effects reported may include drowsiness, diarrhea, dry mouth, and insomnia. More serious side effects, though less common, can occur. Patients should discuss all potential side effects with their doctor and report any concerning or persistent symptoms promptly.

Contraindications and Warnings

Austedo may not be suitable for everyone. It is contraindicated in patients with certain conditions, such as severe liver impairment, or those taking specific medications that interact negatively with Austedo. Important warnings include the potential for depression and suicidal ideation, QT prolongation (an electrical activity problem of the heart), and neuroleptic malignant syndrome (a rare but serious drug reaction). A comprehensive medical history and evaluation are essential before starting Austedo.

Drug Interactions

Austedo can interact with other medications, including certain antidepressants, antipsychotics, and drugs that affect heart rhythm. Patients should inform their doctor about all prescription and over-the-counter medications, vitamins, and herbal supplements they are currently taking to avoid potential drug interactions.

Consulting Your Healthcare Provider

Austedo is a specialized medication that should only be used under the guidance of a healthcare professional. If you or someone you know is experiencing symptoms of tardive dyskinesia or chorea associated with Huntington's disease, it is essential to seek a medical diagnosis and discuss appropriate treatment options with a doctor. They can provide personalized advice, assess suitability for Austedo, and manage any potential side effects or interactions.

This article aims to provide general information about Austedo (deutetrabenazine) by Teva Pharmaceutical Industries. For detailed medical information, always refer to your prescribing information and consult with your healthcare provider.